Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Regulatory News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

Share Price is delayed by 15 minutes
Get Live Data
12.75    0.50 (4.08%)
Bid:
12.50
Ask:
13.00
Spread: 0.50 (4.00%)
Market Cap: £32.01m
ABDX Live PriceLast checked at - London Stock Exchange

Intraday Abingdon Healt. Share Chart

Notice of Results

11 Mar 2024 08:53

RNS Number : 3301G
Abingdon Health PLC
11 March 2024
 

 

 

 

Abingdon Health plc

("Abingdon Health" or "the Company")

 

Notice of Results

 

York, U.K. 11 March 2024: Abingdon Health plc (AIM: ABDX), a leading international lateral flow contract research (CRO) and contract development and manufacturing organisation (CDMO), announces that its interim results for the six months ended 31 December 2023 will be released on 14 March 2024.

 

 

Enquiries

 

Abingdon Health plc

www.abingdonhealth.com/investors/

Chris Yates, Chief Executive Officer

Via Walbrook PR

Chris Hand, Non-Executive Chairman

 

 

 

Singer Capital Markets (Sole Broker and Nominated Adviser)

Tel: +44 (0)20 7496 3000

Peter Steel, Alex Bond, Jalini Kalaravy (Corporate Finance)

 

Tom Salvesen (Corporate Broking)

 

 

About Abingdon Health plc

Abingdon Health is a leading lateral flow contract research (CRO) and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."

The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. 

 

Abingdon Health's Abingdon Simply Test? range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test? ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.

 

Founded in 2008, Abingdon Health is headquartered in York, England. For more information visit: www.abingdonhealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORGIGDXBUBDGSB
Date   Source Headline
29th Mar 20227:11 amRNSInterim Results
29th Mar 20227:00 amRNSStrategic collaboration with Vatic Health Limited
29th Mar 20227:00 amRNSStrategic collaboration with DeepVerge plc
29th Mar 20227:00 amRNSMoU with Abingdon Health for lateral flow tests
25th Mar 20227:00 amRNSNotice of Results
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:01 amRNSTrading and Strategic Update
2nd Mar 20227:00 amRNSUK Government study gives insight on SARS-CoV-2
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:36 pmRNSPrice Monitoring Extension
18th Jan 20222:05 pmRNSSecond Price Monitoring Extn
18th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20229:05 amRNSSecond Price Monitoring Extn
10th Jan 20229:00 amRNSPrice Monitoring Extension
10th Jan 20227:05 amRNSUpdate on AffiDX® SARS-CoV-2 antigen LFT
24th Dec 202110:05 amRNSResult of AGM
22nd Dec 202111:06 amRNSSecond Price Monitoring Extn
22nd Dec 202111:01 amRNSPrice Monitoring Extension
21st Dec 20218:40 amRNSDirector/PDMR Shareholding
20th Dec 202111:01 amRNSResults of General Meeting and Open Offer
16th Dec 20217:00 amRNSCE-marking and commercial launch of Semi-Q Test
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension
3rd Dec 202111:07 amRNSPublication of Annual Report and Notice of AGM
2nd Dec 20215:43 pmRNSOpen Offer Launch, Posting of Circular, GM Notice
1st Dec 20211:47 pmRNSResult of Placing, PrimaryBid and Subscription
1st Dec 202111:06 amRNSSecond Price Monitoring Extn
1st Dec 202111:01 amRNSPrice Monitoring Extension
1st Dec 202110:18 amRNSClose of Accelerated Bookbuild & PrimaryBid Offer
1st Dec 20219:05 amRNSSecond Price Monitoring Extn
1st Dec 20219:00 amRNSPrice Monitoring Extension
1st Dec 20217:01 amRNSPrimaryBid Offer
1st Dec 20217:00 amRNSProposed Fundraising
18th Nov 20214:41 pmRNSSecond Price Monitoring Extn
18th Nov 20214:35 pmRNSPrice Monitoring Extension
18th Nov 20212:05 pmRNSSecond Price Monitoring Extn
18th Nov 20212:00 pmRNSPrice Monitoring Extension
18th Nov 202111:06 amRNSSecond Price Monitoring Extn
18th Nov 202111:00 amRNSPrice Monitoring Extension
18th Nov 20217:00 amRNSPreliminary Results
17th Nov 20214:41 pmRNSSecond Price Monitoring Extn
17th Nov 20214:35 pmRNSPrice Monitoring Extension
15th Nov 20217:00 amRNSNotice of Results
4th Oct 202111:06 amRNSSecond Price Monitoring Extn
4th Oct 202111:00 amRNSPrice Monitoring Extension
7th Sep 20217:00 amRNSLaunch of Semi-Quantitative Accessory to AbC-19™
2nd Sep 20214:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:36 pmRNSPrice Monitoring Extension
24th Aug 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.